Additional file 1 of Prenatal exposure to maternal asthma and asthma medication and neurodevelopmental outcomes: a population cohort study of 179,024 children

Read full text Summarise with VIRAT
Authors: Lama A. Shakhshir, Sarjit Singh, Jill P. Pell, Scott M. Nelson, Daniel Mackay, C. Hastie, Logesh Sivakumar, Michael Fleming
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Additional file 1. Supplementary Fig. 1 and Supplementary Tables 1–8. Supplementary Fig. 1: Directed acyclic graph (DAG) of confounder and mediator variables in the relationship between maternal asthma and child outcomes. Supplementary Table 1: Read codes for asthma diagnosis. Supplementary Table 2: Read codes for asthma medication. Supplementary Table 3: Medication groups. Supplementary Table 4: Read codes for ADHD diagnosis. Supplementary Table 5: Read codes for ADHD medications. Supplementary Table 6: Characteristics and outcomes of cohort participants by presence or absence of maternal asthma. Supplementary Table 7: Associations between treated and untreated maternal asthma and childhood outcomes. Supplementary Table 8: Associations between different combinations of classes of asthma medications and childhood outcomes.

Fields of Study & Subjects

Pregnancy and Medication Impact Asthma and respiratory diseases Prenatal Substance Exposure Effects

Publication details

Journal / source
Figshare
Publication date
20 February 2026
Language
EN